Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility

Pharmacogenetics

Volumn 11, Issue 2, 2001, Pages 157-168

  Wikman, H ^a   Thiel, S ^a   Jager B ^a   Schmezer, P ^a   Spiegelhalder, B ^a   Edler, L ^a   Dienemann, H ^a   Kayser, K ^a   Schulz, V ^a   Drings, P ^a   Bartsch, H ^a   Risch, A ^a  

^a Division of Toxicology and Cancer Risk Factors   (Germany)

Author keywords

Genetic polymorphism; LightCycler; Lung cancer; NAT1; NAT2; PCR RFLP

Indexed keywords

ACYLTRANSFERASE; AROMATIC AMINE;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DEVICE; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TOBACCO;

AGED; ARYLAMINE N-ACETYLTRANSFERASE; BASE SEQUENCE; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; DNA PRIMERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ISOENZYMES; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

NICOTIANA TABACUM;

EID: 17744376645     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-200103000-00006     Document Type: Article

References (50)

1. Association of the NAT1*10 genotype with increased chromosome aberrations and higher lung cancer risk in cigarette smokers
2. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder
3. The role of individual susceptibility in cancer burden related to environmental exposure
4. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancer
5. Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: Association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue
6. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer
7. Human arylamine N-acetyltransferase genes: Isolation, chromosomal localization, and functional expression
8. Identification of N-acetyltransferase 2 genotypes by continuous monitoring of fluorogenic hybridization probes
9. N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk
10. The analysis of case-control studies
11. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk
12. Correlation between genotype and phenotype of the human arylamine N-acetyltransferase Type 1 (NAT1)
13. Functional polymorphism of the human arylamine N-acetyltransferase type 1 gene caused by C190T and G560A mutations
14. Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: Correlation with phenotypic activity
15. Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer
16. Arylamine N-acetyltransferase activity in man
17. Histological localization of acetyltransferases in human tissue
18. A restriction fragment length polymorphism assay that differentiates human N-acetyl-transferase-1 (NAT1) alleles
19. Identification of a novel allele at the human NAT1 acetyltransferase locus
20. N-acetyltransferase 1 genetic polymorphism influences the risk of prostate cancer development
21. Increased frequency of wild-type arylamine-N-acetyltransferase allele NAT2*4 homozygotes in Portuguese patients with colorectal cancer
22. Human acetyltransferase polymorphisms
23. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases
24. Molecular genetics and epidemiology of the NAT1 and NAT2 polymorphisms
25. Association of arylamine N-acetyltransferases NAT1 and NAT2 geno-types to laryngeal cancer risk
26. N-acetyltransferase polymorphism. Comparison of phenotype and genotype in humans
27. Genotyping human polymorphic arylamine N-acetyltransferase: Identification of new slow allotypic variants
28. Chromosomal localization of human genes for arylamine N-acetyltransferase
29. Glutathione Stransferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders
30. GSTM1 and NAT2 polymorphisms and non-operable lung cancer patients
31. Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probe
32. Polymorphisms in the N-acetyltransferase I (NAT1) gene and lung cancer risk in a minority population
33. Meat consumption, genetic susceptibility, and colon cancer risk: A United States multicenter case-control study
34. Quantitation of asbestos and asbestos-like fibers in human lung tissue by hot and wet ashing, and the significance of their presence for survival of lung carcinoma and mesothelioma patients
35. Association of concentration of asbestos and asbestos-like fibers with the patient's survival and the binding capacity of lung parenchyma to galectin-1 and natural alpha-galactoside- and alpha-mannoside-binding immunoglobulin G subfractions from human serum
36. Real-time fluorescence genotyping of factor V Leiden during rapid-cycle PCR
37. Lung cancer and mutations at the polymorphic NAT2 gene locus
38. N- and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells
39. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls
40. N-acetylation polymorphism in patients with lung cancer and its association with p53 gene mutation
41. Genotyping human arylamine N-acetyltransferase type 1 (NAT1)
42. Product differentiation by analysis of DNA melting curves during the polymerase chain reaction
43. Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer
44. Role of NAT2 deficiency in susceptibility to lung cancer among asbestos-exposed individuals
45. NAT2 slow acetylator genotype is associated with increased risk of lung cancer among non-smoking Chinese women in Singapore
46. Placental expression of arylamine N-acetyltransferases: Evidence for linkage disequilibrium between NAT1*10 and NAT2*4 alleles of the two human arylamine N-acetyltransferase loci NAT1 and NAT2
47. The role of N-acetylation polymorphisms in smoking-associated bladder cancer: Evidence of a gene-gene-exposure three-way interaction